Tonight on GeekNights, Daddy two reviews! Now that Scott's beaten it, we talk about Abobo's Big Adventure, but not before we review Trigger!, which is from the same people who brought us the wonderful Spot-It! (Spoilers: it's actually pretty mediocre, and definitely a disappointment next to Spot-It). In the news, Wil Wheaton's Tabletop is a thing, Game Gear games are coming to the 3DS, and Nintendo is trying to make multiplayer more intuitive despite their (sarcastically) glowing history of this.
Tonight on GeekNights, we consider Elevator Source: a "thrilling co-op experience" with "realistic elevator physics" and "cunning, state of the art AI!" Rym has some thoughts on Deus X: Human Revolution after having finished his 27 hours of play, Microsoft Flight is FREE, and Direct2Drive died and took some games with it (also know as "why I only ever buy games from Steam").
Tonight on GeekNights, we consider ye olde strategy guide, which seems to have no place in this modern world. Of course, we talk quite a bit about other things, like THE GIANTS, Deus Ex: Human Revolution, Abobo's Big Adventure, Syndicate's re-release on GoG, and The Binding of Issac. Rym's also really into Game of Thrones recently.
Tonight on GeekNights, we bring you our coverage of MAGFest X! Of course, as much as has changed, much has stayed the same, so be sure to check out our coverage of MAGFest 9 too. But first, in the news, CES brings us an interesting device - the Boxee Box Live TV dongle - that doesn't appear to have a market, and the coming battles over "smart TVs" will go predictably nowhere. Also, Kim Jong-il is set to be Lenined.
Tonight on GeekNights, we discuss videogame reviews like this Super Mario Brothers 3 review. In the news, Chromium issue #44106 and the recent broken CounterStrike update have a lot in common, and Notch gets deserved justice.
Tonight on GeekNights, we review the surprising and interesting Rock of Ages. In the news, id releases Rage, Xenonauts might be X-Com, and Risk Legacy brings statefulness to boardgames (for good or ill, we cannot yet say).